Cetuximab-based or bevacizumab-based first-line treatment in patients with KRAS p.G13D-mutated metastatic colorectal cancer
Modest, Dominik Paul, Reinacher-Schick, Anke, Stintzing, Sebastian, Giessen, Clemens, Tannapfel, Andrea, Laubender, Ruediger Paul, Brodowicz, Thomas, Knittelfelder, Regina, Vrbanec, Damir, Schmiegel,Том:
23
Мова:
english
Журнал:
Anti-Cancer Drugs
DOI:
10.1097/cad.0b013e328352ff1d
Date:
July, 2012
Файл:
PDF, 433 KB
english, 2012
File converter
Більше результатів пошуку
More benefits 
